Acute XXXX : a 9-year retrospective analysis.

@entity1 @entity1151 @entity5048 @entity358 @entity67 @entity551 @entity204
Acute @entity1151 is a substantial cause of morbidity and @entity204 . Although the American College of Chest Physicians Evidence-Based Clinical Practice Guidelines recommend @entity358 in @entity1 with @entity1151 associated with @entity551 , there are few reports of 30-day mortality rates. We performed a retrospective review of @entity358 performed in 96 consecutive @entity1 who had severe, globally @entity5048 right @entity67 as determined by transthoracic echocardiography. Data on @entity1 who were treated from January 2003 through December 2011 were derived from health system databases of the New York State Cardiac Surgery Reporting System and the Society of Thoracic Surgeons. The data represent procedures performed at 3 tertiary care facilities within a large health system operating in the New York City metropolitan area. The overall 30-day mortality rate was 4.2%. Most @entity1 (68 [73.9%]) were discharged home or to rehabilitation facilities (23 [25%]). Hemodynamically stable @entity1 with severe, globally @entity5048 right @entity67 had a 30-day mortality rate of 1.4%, with a postoperative mean length of stay of 9.1 days. Comparable findings for hemodynamically unstable @entity1 were 12.5% and 13.4 days, respectively. Acute @entity358 can be a viable procedure for @entity1 with severe, globally @entity5048 right @entity67 , with or without hemodynamic compromise; however, caution is warranted. Our outcomes might be dependent upon institutional capability, experience, surgical ability, and careful @entity1 selection.
